Avastin Shows Promise For Ovarian Cancer Treatment

Links shared publicly online about this topic.

  • 809
    total visits

Avastin Shows Promise For Ovarian Cancer Treatment

medicalnewstoday.com

Further evidence that Avastin improved progression free survival in women with ovarian cancer was presented by researchers at the European Society of Medical Oncology (ESMO) congress in Milan, Ita

View full resource at medicalnewstoday.com

Tags: Cancer, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Avastin, Oncology

  • Share

Most Recently Shared on October 12, 2010 at 9:39 am By:

OvarianCancer_ Ovarian Cancer OW

Avastin Shows Promise For Ovarian Cancer Treatment: Further evidence that Avastin improved progression free surviv... http://mnt.to/f/3L4P

2 years ago...

Also Shared By:

MNT Health News MNT Health News

MNT Ovarian Cancer MNT Ovarian Cancer

MNT Cancer News MNT Cancer News

Bevacizumab (Avastin) and Ovarian Cancer | The Citizen Oncologist

citizenoncologist.com — “Bevacizumab (Avastin) and Ovarian Cancer | The Citizen OncologistView full resource at citizenoncologist.com

  • View Related
  • Share

Most Recently Shared on December 30, 2011 at 3:10 pm By:

Vaccine For Metastatic Breast, Ovarian Cancer Shows Promise

medicalnewstoday.com — “Treatment with a recombinant poxviral vaccine showed a positive response in both metastatic breast cancer and ovarian cancer, according to a trial published in Clinical Cancer Research, a journalView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 9, 2011 at 9:06 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Vaccine For Metastatic Breast, Ovarian Cancer Shows Promise: Treatment with a recombinant poxviral vaccine showe... http://t.co/4cTEFYpA

5 months ago...

Vaccine to treat cancers promising - USATODAY.com

yourlife.usatoday.com — “Patients with less advanced disease might benefit even more, small study suggests.View full resource at yourlife.usatoday.com

  • View Related
  • Share

Most Recently Shared on November 8, 2011 at 10:47 pm By:

Kathy_Crowley Kathleen Crowley Doctor, Internist, and Physician

Wow -- impressive. Vaccine shows effectiveness in treatment of breast &ovarian CA in pts who hd failed other tx http://t.co/Fhe9Rr40

6 months ago...

Vaccine for metastatic breast, ovarian cancer shows promise

eurekalert.org — “Treatment with a recombinant poxviral vaccine showed a positive response in both metastatic breast cancer and ovarian cancer, according to a trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on November 8, 2011 at 8:52 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Vaccine for metastatic breast, ovarian cancer shows promise: ( American Association for Cancer Research ) Treatm... http://t.co/DZPoguEc

6 months ago...

Harnessing Your Body's Chemistry to Treat Ovarian Cancer

articles.mercola.com — “Low-dose naltrexone (LDN) is an inexpensive prescription treatment that has shown great promise against ovarian cancer and a number of autoimmune diseases.View full resource at articles.mercola.com

  • View Related
  • Share

Most Recently Shared on August 4, 2011 at 11:00 pm By:

mercola Dr. Mercola Doctor, Family Medicine Doctor, and Physician

This breakthrough treatment costs just pennies a day and is showing great promise for #cancer treatment. http://ow.ly/5UQ3o

9 months ago...

Late-stage ovarian cancer therapy shows promise in phase II trial

medicalxpress.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on August 3, 2011 at 6:10 pm By:

physorg_health PhysOrg Health News Health News

Late-stage ovarian cancer therapy shows promise in phase II trial http://tw.medicalxpress.com/231598840

9 months ago...

Late-stage ovarian cancer therapy shows promise in phase II trial: IU News Room: Indiana University

newsinfo.iu.edu — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer. View full resource at newsinfo.iu.edu

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 9:30 pm By:

OncologySupport Oncology Institute Support

Late-stage ovarian cancer therapy shows promise in phase II trial: IU News Room: India http://fb.me/1bLmfGyrn

9 months ago...

ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed Ovarian Cancer - MPR

empr.com — “The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology’s 2011 Annual Meeting.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 5:52 pm By:

eMPR MPR Medical Publisher

#asco2011 ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed… http://goo.gl/fb/a5CpE

11 months ago...

Investigational Ovarian Cancer Drug Shows Promise Against Platinum Resistant Disease

medicalnewstoday.com — “A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research groupView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 12, 2010 at 12:05 pm By:

mnt_genetics MNT Genetics News Health News

Investigational Ovarian Cancer Drug Shows Promise Against Platinum Resistant Disease http://mnt.to/3L3s #genetics

2 years ago...

Roche's Avastin Shows Positive Results - QualityPoint Technologies

qualitypointtech.net — “Roche said fresh trial results for two of its cancer medicines suggest the therapies may improve treatment for women suffering from ovarian and breast cancer. (Source: WSJ.com: Health)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 11, 2010 at 4:12 pm By:

MedicalFeed MedicalFeed Health News Feed

Roche's Avastin Shows Positive Results: Roche said fresh trial results for two of its cancer medicines suggest th... http://bit.ly/dAruYk

2 years ago...

Investigational ovarian cancer drug shows promise against platinum resistant disease

physorg.com — “A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group has reported.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 10, 2010 at 10:08 am By:

FightCancer FightCancer Health News

Investigational ovarian cancer drug shows promise against platinum resistant disease http://bit.ly/cZ4z3q

2 years ago...

Investigational ovarian cancer drug shows promise against platinum resistant disease

eurekalert.org — “A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group has reportedView full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on October 9, 2010 at 3:29 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Investigational ovarian cancer drug shows promise against platinum resistant disease: ( European Society for Medic... http://bit.ly/aV9uJB

2 years ago...

Our view on drug approvals: Let science guide policy on costly breast cancer treatments - USATODAY.com

usatoday.com — “At $8,000 a month, Avastin shows little promise for breast cancer.View full resource at usatoday.com

  • View Related
  • Share

Most Recently Shared on August 24, 2010 at 5:04 pm By:

PhysicianAssist Physician Assistants Health News Feed

Praises for FDA's Reliance On Science In Drug Approval Decisions: http://bit.ly/dpnRcX

2 years ago...

Olaparib -- A Novel Drug To Treat Hereditary Breast & Ovarian Cancer Video

vodpod.com — “Dr Andrew Tutt, Consultant Clinical Oncologist and Director of the Breakthrough Breast Cancer Research Unit at King's College London, discussing olaparib, the first of a totally new type of cancer treatments that is showing promise for patients with inherited forms of breast and ovarian cancer. 06 Jul 10.View full resource at vodpod.com

  • View Related
  • Share

Most Recently Shared on July 6, 2010 at 3:53 pm By:

libbyshope Paul Cacciatore Patient Advocate

Dr Andrew Tutt, Consultant Clinical Oncologist and Director of the Breakthrough Breast Cancer Research Unit at King's … http://bit.ly/9EuSOn

2 years ago...

Advertisement